Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03737604 · ClinicalTrials.gov registry record · Phase 4

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

A Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney, sponsored by University of California, Davis.

Recruiting
Registry status
Phase 4
Development phase
200
Enrollment target
1
Study location

NCT03737604: Recruiting Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney, sponsored by University of California, Davis.

NCT03737604 is a Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 200 participants, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03737604, a Phase 4 study of Pain, Postoperative and Transplant;Failure,Kidney, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

Primary Outcome

Total amount of opioid analgesic administered following renal transplant surgery converted using standard equivalency calculations to morphine equivalents mg/kg

Interventions

  • DRUG Ropivacaine Continuous Infusion Catheter
  • DRUG Single Dose Liposomal Bupivicaine

Study Locations (1)

California

  • University of California Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-10-04
Est. Completion 2026-06-12
Phase Phase 4
University of California, Davis

657 total trials

What NCT03737604 shows while recruiting

NCT03737604 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (26% lower).

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine Continuous Infusion Catheter is the first listed.

NCT03737604 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03737604 about?

NCT03737604 is a clinical study titled "TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant". This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.

What is the current status of trial NCT03737604?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2018-10-04. Estimated completion is 2026-06-12.

What conditions does trial NCT03737604 study?

This clinical trial studies the following conditions: Pain, Postoperative, Transplant;Failure,Kidney.

What interventions are being tested in trial NCT03737604?

The interventions under investigation include: Ropivacaine Continuous Infusion Catheter (DRUG), Single Dose Liposomal Bupivicaine (DRUG).

Who is sponsoring clinical trial NCT03737604?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03737604 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03737604's enrollment target sits among peer trials

200 17th of 113 higher than 95 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03737604, the US trial registry maintained by the National Library of Medicine. NCT03737604 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.